SXL 05 - Selexel

Drug Profile

SXL 05 - Selexel

Alternative Names: SXL05

Latest Information Update: 08 Sep 2016

Price : $50

At a glance

  • Originator SeleXel
  • Class Antineoplastics
  • Mechanism of Action RNA interference; Small interfering RNA modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Breast cancer; Prostate cancer

Most Recent Events

  • 08 Sep 2016 Preclinical trials in Breast cancer in France (Parenteral)
  • 08 Sep 2016 Preclinical trials in Prostate cancer in France (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top